no image available Dickens & Co. "Breakthrough in Treatment: Infiliximab Offers New Hope for Patients with Refractory Behçet's Syndrome" "Case Report: The Unexpected Efficacy of Infliximab in a Patient with Unresponsive Behçet's Syndrome" Price: 28.00€